Compare CADL & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | MGPI |
|---|---|---|
| Founded | 1999 | 1941 |
| Country | United States | United States |
| Employees | 55 | 267 |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 398.0M |
| IPO Year | 2021 | 1994 |
| Metric | CADL | MGPI |
|---|---|---|
| Price | $4.79 | $18.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $19.71 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 1.2M | 320.9K |
| Earning Date | 03-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | ★ 58.62 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $125,000.00 | ★ $19,782,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.25 | $16.45 |
| 52 Week High | $7.24 | $33.75 |
| Indicator | CADL | MGPI |
|---|---|---|
| Relative Strength Index (RSI) | 42.63 | 43.57 |
| Support Level | $4.58 | $16.45 |
| Resistance Level | $5.42 | $26.44 |
| Average True Range (ATR) | 0.24 | 0.74 |
| MACD | 0.01 | 0.36 |
| Stochastic Oscillator | 28.15 | 77.50 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.